Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs4573554 | chr1:56398037 | C/T | 0.000165 | 178 | 25.53 | 26.27 | 15.8 | KM Plot |
PCPG | rs458197 | chr3:161092764 | G/A | 0.000254 | 172 | 25.47 | 23.43 | 3.17 | KM Plot |
PCPG | rs4585710 | chr8:11303828 | C/T | 7.79E-6 | 178 | 25.67 | 19.57 | 14.15 | KM Plot |
PCPG | rs4597327 | chr16:90054955 | A/G | 1.11E-8 | 172 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs4597510 | chr2:61583927 | T/C | 6.43E-5 | 178 | 23.43 | 29.88 | 10.3 | KM Plot |
PCPG | rs4605214 | chr17:50282834 | C/T | 6.07E-5 | 178 | 25.77 | 27.6 | 14.47 | KM Plot |
PCPG | rs4619132 | chr11:18152386 | T/C | 4.63E-6 | 175 | 26.43 | 23.48 | 10.3 | KM Plot |
PCPG | rs4624036 | chr13:37521738 | T/C | 0.000345 | 174 | 4.17 | 19.1 | 26.57 | KM Plot |
PCPG | rs4632682 | chr4:78951867 | A/G | 0 | 176 | 2.93 | 25.87 | 25.28 | KM Plot |
PCPG | rs4675917 | chr2:242557785 | C/T | 4.36E-5 | 178 | 19.75 | 29.57 | 25.87 | KM Plot |
PCPG | rs4675924 | chr2:242538496 | A/G | 3.49E-5 | 175 | 25.87 | 29.57 | 20.2 | KM Plot |
PCPG | rs4675925 | chr2:242522140 | A/G | 4.96E-5 | 176 | 25.87 | 27.62 | 19.75 | KM Plot |
PCPG | rs4675927 | chr2:242516487 | C/G | 4.6E-5 | 177 | 25.87 | 29.57 | 19.75 | KM Plot |
PCPG | rs4686766 | chr3:184524522 | C/T | 1.02E-5 | 178 | 24.7 | 25.77 | 25.17 | KM Plot |
PCPG | rs4713007 | chr6:26537609 | A/G | 6.12E-7 | 178 | 10.68 | 32.6 | 24.53 | KM Plot |